Venetoclax Plus Ibrutinib As First-Line Treatment in Patients With Chronic Lymphocytic Leukemia: Meta-Analysis of Randomised Controlled Trials — Lokman Hekim Tanrıverdi (2024) | RDL Network
Jan A. Burger, Kelvin W. Li, Michael J. Keating, Mariela Sivina, Ahmed M. Amer, Naveen Garg, Alessandra Ferrajoli, Xuelin Huang, Hagop Kantarjian, William G. Wierda, Susan O’Brien, Marc Hellerstein, Scott Turner, Claire Emson, Shih‐Shih Chen, Xiao‐Jie Yan, Dominik Wodarz, Nicholas Chiorazzi
Discussion(0)
No comments yet. Be the first to comment.